More specifically speaking, Sterlings group observed a decreased percentage of newly diagnosed glaucoma after GLP-1RAs exposure from 1.33% to 0.51%, and Chuangs research discovered lowered glaucoma onset with a significant adjusted hazard ratio (aHR) (0.712, 95% CI: 0.5330.936
Wegovy: Whats the Difference and Which Is Right for You
Glucagon-like peptide-1 (GLP-1) receptor agonists represent a class of medications increasingly prescribed for type 2 diabetes management and, more recently, for chronic weight management
Sinclair EM, Drucker DJ
"New drugs targeting other pathways could reassure those patients and give them hope." GLP-1 agonists are already under study for various health benefits beyond diabetes management, such as reducing heart disease risks and treating neurological conditions like Alzheimer's
(e) and lifestyle assessment including aerobic activity, strength training, sleep, mental stress, substance use, and social connections